Quadrant Capital Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,940
| Closed | -$13.1K | – | 2114 |
|
|
2025
Q1 | $13.1K | Buy |
5,940
+4,263
| +254% | +$9.42K | ﹤0.01% | 2152 |
|
|
2024
Q4 | $9.14K | Sell |
1,677
-1,940
| -54% | -$10.6K | ﹤0.01% | 2151 |
|
|
2024
Q3 | $30.1K | Sell |
3,617
-1,114
| -24% | -$9.26K | ﹤0.01% | 1723 |
|
|
2024
Q2 | $33.9K | Sell |
4,731
-204
| -4% | -$1.46K | ﹤0.01% | 1607 |
|
|
2024
Q1 | $42.8K | Buy |
4,935
+1,666
| +51% | +$14.4K | ﹤0.01% | 1483 |
|
|
2023
Q4 | $21.4K | Buy |
3,269
+3
| +0.1% | +$20 | ﹤0.01% | 1789 |
|
|
2023
Q3 | $32.7K | Buy |
3,266
+2,511
| +333% | +$25.1K | ﹤0.01% | 1472 |
|
|
2023
Q2 | $9.39K | Sell |
755
-1,578
| -68% | -$19.6K | ﹤0.01% | 2016 |
|
|
2023
Q1 | $32.7K | Buy |
2,333
+1,688
| +262% | +$23.6K | ﹤0.01% | 1456 |
|
|
2022
Q4 | $9.23K | Buy |
645
+429
| +199% | +$6.14K | ﹤0.01% | 1987 |
|
|
2022
Q3 | $6K | Buy |
+216
| New | +$6K | ﹤0.01% | 2079 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | – | – | 2621 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2631 |
|
|
2021
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2594 |
|